Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 4/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | RGS12 | O14924 | 1/20 | 0.52 |
| ▸ | GLA | P06280 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14388207 | 1.00 | AOC3 (0.58) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL14387920 | 1.00 | AOC3 (0.58) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL10255083 | 1.00 | AOC3 (0.58) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL14388140 | 1.00 | AOC3 (0.58) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL5160626 | 0.87 | AOC3 (0.55) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL6736128 | 0.84 | LMNA (0.59) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL7531733 | 0.83 | AOC3 (0.59) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL1173366 | 0.83 | AOC3 (0.59) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL20644456 | 0.82 | AOC3 (0.40) | AOC3LMNAADRA2CKDM4EADRA2A | |
| SCHEMBL359794 | 0.82 | KDM4E (0.57) | AOC3LMNAADRA2CKDM4EADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | claimed |
| CN-106905682-A | A kind of Halogen phosphorus silicon cooperative flame retardant polycarbafil/ASA resin alloy and preparation method thereof | 武汉理工大学 | 2017-06-30 | — | — | CN | claimed |
| US-6894084-B2 | No VOC radiation curable resin compositions | FOSTER-MILLER, INC. (US) | 2005-05-17 | — | — | US | claimed |
| US-20020193460-A1 | No VOC radiation curable resin compositions | KOVAR ROBERT F (US) | 2002-12-19 | — | — | US | claimed |
| CN-119771400-A | Metal nanocluster, preparation method and application thereof, and method for coupling terminal olefin with benzyl alcohol compound | 中国石油化工股份有限公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119403843-A | Polymer and method for producing same, photosensitive resin composition, cured product, and monomer compound and method for producing same | 株式会社日本触媒 | 2025-02-07 | — | — | CN | disclosed |
| CN-110144139-B | Zinc oxide-based nanoparticle ink and photoelectric device | 纳晶科技股份有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-20210322518-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | AMUNIX PHARMACEUTICALS, INC. | 2021-10-21 | — | — | US | disclosed |
| CN-110392601-A | Electret sheet material and filter | 优泊公司 | 2019-10-29 | — | — | CN | disclosed |
| CN-110144139-A | A kind of zinc oxide base nano particle ink and photoelectric device | 纳晶科技股份有限公司 | 2019-08-20 | — | — | CN | disclosed |
| EP-2780039-B9 | CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF | PFIZER (US) | 2018-04-18 | — | — | EP | disclosed |
| WO-2017134547-A1 | TUBULYSIN ANALOGS AND METHODS FOR THEIR PREPARATION | PFIZER INC. (US) | 2017-08-10 | — | — | WO | disclosed |
| WO-2001060870-A1 | NO VOC RADIATION CURABLE RESIN COMPOSITIONS | FOSTER MILLER, INC. (US) | 2001-08-23 | — | — | WO | disclosed |
| US-6207739-B1 | Polyamide acid composition containing metal, polyimide film, flexible printed wiring board and method for producing them | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI (JP) | 2001-03-27 | — | — | US | disclosed |
| EP-0985649-A2 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES, INC. (JP) | 2000-03-15 | — | — | EP | disclosed |
| EP-0919607-A2 | Lubricant for mechanical working of materials and additive for the lubricant | Rhenus Lub GmbH & Co. KG (DE) | 1999-06-02 | — | — | EP | disclosed |
| EP-0722436-A4 | MERCAPTOSULFIDE METALLOPROTEINASE INHIBITORS | UNIV FLORIDA STATE (US) | 1996-11-20 | — | — | EP | disclosed |
| EP-0722436-A1 | MERCAPTOSULFIDE METALLOPROTEINASE INHIBITORS | FLORIDA STATE UNIVERSITY (US) | 1996-07-24 | — | — | EP | disclosed |
| WO-1995009833-A1 | MERCAPTOSULFIDE METALLOPROTEINASE INHIBITORS | FLORIDA STATE UNIVERSITY (US) | 1995-04-13 | — | — | WO | disclosed |
| US-4111917-A | POLYURETHANES | W. R. GRACE & CO. (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210322518-A1 | XTEN CONJUGATE COMPOSITIONS AND METHODS OF MAKING SAME | XPA, TXLNA, NGLY1 | AOC3 2524/4885LMNA 2236/4885ADRA2C 4352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.